U.S. flag

An official website of the United States government

Filters

reset all
See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 99

Tests names and labsConditionsGenes, analytes, and microbesMethods

OnkoRisk Hereditary Oncology Plus Panel

BioReference Health
United States
9777
  • C Sequence analysis of the entire coding region

OtoSCOPE v9

Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics
United States
288218
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Schwannomatosis Panel on Tumor Block

Medical Genomics Laboratory Department of Genetics UAB
United States
23
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neurofibromatosis Type 2 (NF2) Next Genetration Sequencing and Deletion/Duplication Testing

Medical Genomics Laboratory Department of Genetics UAB
United States
11
  • L Linkage analysis
  • C Sequence analysis of the entire coding region

NF2-related Schwannomatosis Comprehensive Testing from Paraffin Embedded Biopsy Specimen

Medical Genomics Laboratory Department of Genetics UAB
United States
11
  • L Linkage analysis
  • C Sequence analysis of the entire coding region

FAMILIAL SCHWANNOMATOSI - SMARCB1/INI1 gene

Clinical Genomics Unit Hospital Universitari Germans Trias i Pujol
Spain
23
  • D Deletion/duplication analysis
  • L Linkage analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

NEUROFIBROMATOSI DE TYPE 2 - NF2 gene

Clinical Genomics Unit Hospital Universitari Germans Trias i Pujol
Spain
33
  • D Deletion/duplication analysis
  • L Linkage analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

MVL Vision Panel

Molecular Vision Laboratory
United States
13581028
  • C Sequence analysis of the entire coding region

CentoCancer Comprehensive

Centogene AG - the Rare Disease Company
Germany
156107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
218135
  • C Sequence analysis of the entire coding region

NF2 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Noonan spectrum disorder Comprehensive panel

HNL Genomics Connective Tissue Gene Tests
United States
3125
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Noonan spectrum disorder Deletion / Duplication panel

HNL Genomics Connective Tissue Gene Tests
United States
3125
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neurofibromatosis and related disorders Comprehensive panel

HNL Genomics Connective Tissue Gene Tests
United States
36
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Noonan spectrum disorder NGS panel

HNL Genomics Connective Tissue Gene Tests
United States
3125
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Neurofibromatosis and related disorders NGS panel

HNL Genomics Connective Tissue Gene Tests
United States
36
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Neurofibromatosis and related disorders Deletion / Duplication panel

HNL Genomics Connective Tissue Gene Tests
United States
36
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Neurofibromatosis, type 2, 101000, Autosomal dominant; NF2 (Neurofibromatosis type 2) (NF2 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Neurofibromatosis, type 2, 101000, Autosomal dominant; NF2 (Neurofibromatosis type 2) (NF2 gene) (Sequence Analysis-All Coding Exons) (Prenatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Invitae Genetic Health Screen

Invitae
United States
409164
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 99

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.